BTLA Activators are chemicals that can indirectly influence the activity of the BTLA protein. These activators primarily modulate the signaling pathways that BTLA is involved in, rather than directly binding to and activating the protein itself. These chemicals include PKC activators such as PMA, calcium ionophores like Ionomycin, TLR4 stimulators such as LPS, and various chemicals that alter T cell activation such as Anti-CD3 and Anti-CD28 antibodies. Also included are chemicals that modulate calcium signaling like Cyclosporin A and FK506, protein phosphatase inhibitors like Okadaic acid and Calyculin A, and kinase inhibitors like Staurosporine, Bisindolylmaleimide I, and Genistein.
The activation of BTLA by these chemicals takes place through a variety of mechanisms, mainly by influencing the cellular processes and signaling pathways that BTLA is a part of. For example, chemicals that modulate PKC or calcium signaling can indirectly affect BTLA by altering the activity of these signaling pathways, which are crucial for T cell activation and function. Similarly, chemicals that stimulate TLR4 or T cell activation can also indirectly influence BTLA signaling, as these pathways are interconnected and influence each other. On the other hand, inhibitors of protein phosphatases or kinases can modify the phosphorylation state of proteins involved in BTLA signaling, thereby indirectly affecting the activity of BTLA.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which has been found to indirectly modulate BTLA signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that can increase intracellular calcium concentrations. Calcium signaling is crucial for T-cell activation and can indirectly influence BTLA. | ||||||
Doxycycline Hyclate | 24390-14-5 | sc-204734B sc-204734 sc-204734A sc-204734C | 100 mg 1 g 5 g 25 g | $27.00 $50.00 $105.00 $194.00 | 25 | |
Doxycycline Hyclate can stimulate Toll-like receptor 4 (TLR4), which then modulates various immune responses, potentially influencing BTLA signaling indirectly. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits the activity of calcineurin, thus modulating calcium signaling and potentially influencing BTLA indirectly. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Similar to Cyclosporin A, FK506 also inhibits calcineurin and can indirectly modulate BTLA. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases, which can indirectly affect BTLA signaling by modulating the phosphorylation state of proteins in the pathway. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic acid, Calyculin A inhibits protein phosphatases and can influence BTLA signaling indirectly. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor. By altering kinase activity, it can indirectly modify BTLA signaling. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of PKC. By modulating PKC activity, it can indirectly influence BTLA signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a broad-spectrum tyrosine kinase inhibitor. By altering tyrosine kinase activity, it can indirectly affect BTLA signaling. | ||||||